Pfizer Unveils $1 Billion Manufacturing Facility in Tuas Biomedical Park

Pfizer Unveils $1 Billion Manufacturing Facility in Tuas Biomedical Park

23 Jul, 2024

 Pfizer Unveils $1 Billion Manufacturing Facility in Tuas Biomedical Park

Pfizer has opened a new $1 billion Active Pharmaceutical Ingredient (API) manufacturing facility in Tuas Biomedical Park, Singapore. The 429,000 sq ft facility will produce small molecule APIs for oncology, pain, and antibiotic medicines, creating over 250 jobs. Designed for future expansions, it includes processing suites, a warehouse, and energy-efficient technologies. The facility holds a Green Mark Gold certification, underscoring Pfizer's commitment to sustainability.

Related News

Despite Hype Only 27% of Singapore Businesses Have Adopted AI

20 Nov, 2024

A recent HubSpot report reveals that despite Singapore’s growing focus…
Read More
CM Mohan Charan Majhi urges Singapore leaders to explore Odisha

18 Nov, 2024

Chief Minister Mohan Charan Majhi on Sunday urged investors and…
Read More
Singapore Life Market Sees 23.5% Growth in New Premiums

14 Nov, 2024

Singapore's life insurance industry achieved a milestone, recording a total…
Read More
Tatas to Select Singapore as Key Partner for Semiconductor Venture

12 Nov, 2024

Tata Sons is set to select Singapore as a key…
Read More
HCLTech Unveils AI/Cloud Native Lab in Singapore Partnering with Government

04 Nov, 2024

HCLTech Unveils AI/Cloud Native Lab in Singapore, Partnering with Government…
Read More
Infobip and Singtel Collaborate to Enhance Customer Engagement in Singapore

28 Oct, 2024

Infobip, a global leader in omnichannel communications, has partnered with…
Read More

Interview

© 2024 Business International News. All rights reserved | Powered by Cred Matters.